EUVIMEDEUVIMED entdecken
Crossref

Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo

Jean Ikanga iD, Kharine Jean iD, Priscilla Medina iD, Saranya Sundaram Patel iD, Megan Schwinne iD, Emmanuel Epenge iD, Guy Gikelekele iD, Nathan Tshengele iD, Immaculee Kavugho, Samuel Mampunza, Lelo Mananga, Charlotte E Teunissen iD und 9 weitere

Journal of Alzheimer’s Disease · 2025-09 · 107 (2) · 628-640

DOI: 10.1177/13872877251360697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025-09. Verfasst von Jean Ikanga und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Hippocampus, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hippocampal atrophy is a key feature of Alzheimer's disease (AD), but neuroimaging is often inaccessible in low-resource settings. Blood-based biomarkers such as amyloid-β (Aβ 42/40 ), phosphorylated tau-181 (p-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) may offer a practical alternative, though their utility in African populations remains understudied.

Objective

This study investigated the ability of plasma biomarkers of AD and AD-related dementias—Aβ 42/40 , p-tau181, NfL, and GFAP—to predict hippocampal atrophy in older adults in Kinshasa, Democratic Republic of Congo.

Methods

Eighty-five adults aged over 65 (40 healthy; 45 suspected AD) were recruited. Core AD (Aβ 42/40 , p-tau181) and non-specific (NfL, GFAP) biomarkers were analyzed. Hippocampal volumes were measured using MRI. Linear and logistic regressions assessed biomarker differences by age, sex, and neurological status, and predicted hippocampal atrophy.

Results

Elevated p-tau181 was associated with left hippocampal (LH) atrophy (p = 0.020), with 4.2-fold increased odds [OR = 4.2 (1.5–18.4)] of LH atrophy per standard deviation increase. The areas under the curve of plasma biomarkers without clinical covariates to discriminate LH, right hippocampal (RH), and total hippocampal (TH) atrophy ranged from 90%–94%, 76%–82%, and 85%–87%, respectively. Models including clinical covariates and biomarkers improved discrimination to 94%–96% (LH), 81%–84% (RH), and 88%–90% (TH).

Conclusions

Consistent with findings from other settings, core AD plasma biomarkers can effectively predict hippocampal atrophy in a Sub-Saharan African population, supporting their potential for scalable dementia screening where imaging is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusAlzheimer DiseaseHumansMaleFemaleAtrophyAgedBiomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament ProteinsDemocratic Republic of the CongoGlial Fibrillary Acidic ProteinMagnetic Resonance ImagingAged, 80 and overPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseaseCongobiomarkersdementia

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament ProteinsGlial Fibrillary Acidic ProteinPeptide Fragmentsneurofilament protein LGFAP protein, human

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • School of Medicine, Kinshasa, Department of Psychiatry, University of Kinshasa and Catholic University of Congo, Kinshasa, Democratic Republic of Congo.
  • Department of Psychology, Mercer University, Atlanta, GA, USA.
  • OneRehab, Dallas, TX, USA.
  • School of Medicine, Department of Biomedical Informatics, Emory University, Atlanta, GA, USA.
  • Department of Neurology, Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of Congo.

ORCID-Profile: Jean Ikanga, Kharine Jean, Priscilla Medina, Saranya Sundaram Patel, Megan Schwinne, Emmanuel Epenge, Guy Gikelekele, Nathan Tshengele, Charlotte E Teunissen, Anthony Stringer, Julio C Rojas, Brandon Chan, Argentina Lario Lago, Alvaro Alonso

Förderung

  • National Institute on Aging

Zitieren

APA

Ikanga, J., Jean, K., Medina, P., Patel, S. S., Schwinne, M., Epenge, E., Gikelekele, G., Tshengele, N., Kavugho, I., Mampunza, S., Mananga, L., Teunissen, C. E., Stringer, A., Rojas, J. C., Chan, B., Lago, A. L., Boxer, A. L., Jeromin, A., Hanseeuw, B., …, & Alonso, A. (2025). Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo. Journal of Alzheimer’s Disease, 107(2), 628-640. https://doi.org/10.1177/13872877251360697

Vancouver

Ikanga J, Jean K, Medina P, Patel SS, Schwinne M, Epenge E, et al. Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo. Journal of Alzheimer’s Disease. 2025;107(2):628-640. doi:10.1177/13872877251360697

BibTeX
@article{Ikanga2025,
  author = {Ikanga, Jean and Jean, Kharine and Medina, Priscilla and Patel, Saranya Sundaram and Schwinne, Megan and Epenge, Emmanuel and Gikelekele, Guy and Tshengele, Nathan and Kavugho, Immaculee and Mampunza, Samuel and Mananga, Lelo and Teunissen, Charlotte E and Stringer, Anthony and Rojas, Julio C and Chan, Brandon and Lago, Argentina Lario and Boxer, Adam L and Jeromin, Andreas and Hanseeuw, Bernard and Gross, Alden L and Alonso, Alvaro},
  title = {Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  volume = {107},
  number = {2},
  pages = {628--640},
  doi = {10.1177/13872877251360697}
}
Kostenlos starten →